Immune checkpoint inhibitors a new player in the therapeutic game of mesothelioma: New reality with new challenges
Abstract
Abstract
Malignant pleural mesothelioma (MPM) is a rare and orphan thoracic malignancy, with a poor prognosis as the majority of patients are diagnosed with unresectable MPM, with no significant improvements in the therapeutic strategy for over a decade. However, the recent approval of immune checkpoint inhibitors (ICI) in treatment-naïve patients with unresectable MPM marks a significant step forward and hope for the treatment of this...Paper Details
Title
Immune checkpoint inhibitors a new player in the therapeutic game of mesothelioma: New reality with new challenges
Published Date
Sep 1, 2021
Journal
Volume
99
Pages
102250 - 102250
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History